Safety Study of PRLX 93936 in Patients With Advanced Solid Tumors

NCT00528047 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
37
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Prolexys Pharmaceuticals